Comparison of guidelines for HIV viral load monitoring among pregnant and breastfeeding women in sub-Saharan Africa

• Published in: AIDS (London) Vol. 34; no. 2; pp. 311 - 315
• Main Authors: Lesosky, Maia, Raboud, Janet M, Glass, Tracy, Brummel, Sean S, Ciaranello, Andrea L, Currier, Judith S, Essajee, Shaffiq, Havlir, Diane V, Koss, Catherine A, Ogwu, Anthony, Shapiro, Roger L, Abrams, Elaine J, Myer, Landon
• Format: Journal Article
• Language: English
• Published: England Copyright Wolters Kluwer Health, Inc 01.02.2020
• Subjects: Africa South of the Sahara; Anti-HIV Agents - therapeutic use; Breast Feeding; Female; Fertilization; HIV Infections - drug therapy; HIV Infections - virology; Humans; Infectious Disease Transmission, Vertical - prevention & control; Monte Carlo Method; Postpartum Period; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious - drug therapy; Serologic Tests; Viral Load; Africa South of the Sahara
• ISSN: 0269-9370; 1473-5571
• DOI: 10.1097/QAD.0000000000002400

BACKGROUND:Intensified viral load monitoring for pregnant and breastfeeding women has been proposed to help address concerns around antiretroviral therapy (ART) adherence, viraemia and transmission risk, but there have been no systematic evaluations of existing policies. METHODS:We used an individual Monte Carlo simulation to describe longitudinal ART adherence and viral load from conception until 2 years’ postpartum. We applied national and international guidelines for viral load monitoring to the simulated data. We compared guidelines on the percentage of women receiving viral load monitoring and the percentage of women monitored at the time of elevated viral load. RESULTS:Coverage of viral load monitoring in pregnancy and breastfeeding varied markedly, with between 14% and 100% of women monitored antenatally and 38–98% monitored during breastfeeding. Specific recommendations for testing at either a fixed gestation or a short, fixed period after ART initiation achieved more than 95% testing in pregnancy but this was much lower (14–83%) among guidelines with no special stipulations. By the end of breastfeeding, only a small proportion of simulated episodes of elevated viral load more than 1000 copies/ml were successfully detected by monitoring (range, 20–50%). DISCUSSION:Although further research is needed to understand optimal viral load frequency and timing in this population, these results suggest that current policies yield suboptimal detection of elevated viral load in pregnant and breastfeeding women.